Jacob M. Wozniak

Jacob M. Wozniak

Auto-generated profile, based on publicly available information

Jacob M. Wozniak

Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell
Verified
Journal Article
Closed access
SMSebastian Markmiller
Sebastian Markmiller
SSSahar Soltanieh
Sahar Soltanieh
KSKari L. Server
Kari L. Server
RMRaymond Mak
Raymond Mak
WJWenhao Jin
Wenhao Jin
GYGene W. Yeo
Gene W. Yeo

3 September 2020 in Cell
Verified
Journal Article
Closed access
JWJacob M. Wozniak
Jacob M. Wozniak
RMRobert H. Mills
Robert H. Mills
JOJoshua Olson
Joshua Olson
JCJR Caldera
JR Caldera
GSGregory D. Sepich-Poore
Gregory D. Sepich-Poore
DGDavid J. Gonzalez
David J. Gonzalez

1 January 2020 in Food Chemistry
Verified
Journal Article
Closed access
JGJulia M. Gauglitz
Julia M. Gauglitz
CAChristine M. Aceves
Christine M. Aceves
AAAlexander A. Aksenov
Alexander A. Aksenov
GAGajender Aleti
Gajender Aleti
JAjehad almaliti
jehad almaliti
PDPieter C. Dorrestein
Pieter C. Dorrestein

20 May 2019 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
SGStephanie Grainger
Stephanie Grainger
NNNicole Nguyen
Nicole Nguyen
JRJenna Richter
Jenna Richter
JSJordan Setayesh
Jordan Setayesh
BLBrianna Lonquich
Brianna Lonquich
DTDavid Traver
David Traver

1 August 2017 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
JLJohn D. Lapek
John D. Lapek
MLMary K. Lewinski
Mary K. Lewinski
JWJacob M. Wozniak
Jacob M. Wozniak
JGJohn Guatelli
John Guatelli
DGDavid J. Gonzalez
David J. Gonzalez
The mechanisms by which human immunodeficiency virus (HIV) circumvents and coopts cellular machinery to replicate and persist in cells are not fully understood. HIV accessory proteins play key roles in the HIV life cycle by altering host pathways that are often dependent on post-translational modifications (PTMs). Thus, the identification of HIV accessory protein host targets and their PTM status is critical to fully understand how HIV invades, avoids detection and replicates to spread infection. To date, a comprehensive characterization of HIV accessory protein host targets and modulation of their PTM status does not exist. The significant gap in knowledge regarding the identity and PTMs of HIV host targets is due, in part, to technological limitations. Here, we applied current mass spectrometry techniques to define mechanisms of viral protein action by identifying host proteins whose abundance is affected by the accessory protein Vpr and the corresponding modulation of down-stream signaling pathways, specifically those regulated by phosphorylation. By utilizing a novel, inducible HIV-1 CD4+ T-cell model system expressing either the wild type or a vpr-negative viral genome, we overcame challenges associated with synchronization and infection-levels present in other models. We report identification and abundance dynamics of over 7000 proteins and 28,000 phospho-peptides. Consistent with Vpr9s ability to impair cell-cycle progression, we observed Vpr-mediated modulation of spindle and centromere proteins, as well as Aurora kinase A and cyclin-dependent kinase 4 (CDK4). Unexpectedly, we observed evidence of Vpr-mediated modulation of the activity of serine/arginine-rich protein-specific kinases (SRPKs), suggesting a possible role for Vpr in the regulation of RNA splicing. This study presents a new experimental system and provides a data-resource that lays the foundation for validating host proteins and phosphorylation-pathways affected by HIV-1 and its accessory protein Vpr.

23 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
GLGema Lordén
Gema Lordén
JWJacob M. Wozniak
Jacob M. Wozniak
KDKim Doré
Kim Doré
LDLara E. Dozier
Lara E. Dozier
CCChelsea Cates-Gatto
Chelsea Cates-Gatto
ANAlexandra C. Newton
Alexandra C. Newton
Exquisitely tuned activity of protein kinase C (PKC) isozymes is essential to maintaining cellular homeostasis. Whereas loss-of-function mutations are generally associated with cancer, gain-of-function variants in one isozyme, PKCα, are associated with Alzheimer’s disease (AD). Here we show that the enhanced activity of one variant, PKCα M489V, is sufficient to rewire the brain phosphoproteome, drive synaptic degeneration, and impair cognition in a mouse model. This variant causes a modest 30% increase in catalytic activity without altering on/off activation dynamics or stability, underscoring that enhanced catalytic activity is sufficient to drive the biochemical, cellular, and ultimately cognitive effects observed. Analysis of hippocampal neurons from PKCα M489V mice reveals enhanced amyloid-β-induced synaptic depression and reduced spine density compared to wild-type mice. Behavioral studies reveal that this mutation alone is sufficient to impair cognition, and, when coupled to a mouse model of AD, further accelerates cognitive decline. The druggability of protein kinases positions PKCα as a promising therapeutic target in AD.